Edition:
United Kingdom

Conformis Inc (CFMS.OQ)

CFMS.OQ on NASDAQ Stock Exchange Global Select Market

0.51USD
16 Nov 2018
Change (% chg)

$-0.02 (-3.74%)
Prev Close
$0.54
Open
$0.53
Day's High
$0.53
Day's Low
$0.50
Volume
56,227
Avg. Vol
59,639
52-wk High
$3.34
52-wk Low
$0.50

Latest Key Developments (Source: Significant Developments)

ConforMIS Q2 Loss Per Share $0.24
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - ConforMIS Inc ::CONFORMIS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.24.Q2 REVENUE $19.1 MILLION VERSUS I/B/E/S VIEW $19.3 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.21 -- THOMSON REUTERS I/B/E/S.  Full Article

ConforMIS Sees FY 2018 Revenue $79.6 Mln To $83.6 Mln
Monday, 8 Jan 2018 

Jan 8 (Reuters) - ConforMIS Inc ::SEES ‍Q4 TOTAL REVENUE OF ABOUT $20.8 MILLION, DOWN 4% YEAR-OVER-YEAR ON A REPORTED BASIS​.CONFORMIS REPORTS PRELIMINARY FOURTH QUARTER AND YEAR-END 2017 REVENUE RESULTS; PROVIDES 2018 FINANCIAL GUIDANCE.SEES FY 2018 REVENUE $79.6 MILLION TO $83.6 MILLION.SEES 2017 TOTAL REVENUE OF APPROXIMATELY $78.1 MILLION, DOWN 2% YEAR-OVER-YEAR.FY2017 REVENUE VIEW $77.3 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $84.2 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Conformis Q3 loss per share $0.29
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Conformis Inc ::Conformis reports third quarter 2017 financial results.Q3 loss per share $0.29.Q3 revenue $18.4 million versus I/B/E/S view $17.6 million.Q3 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S.  Full Article

Conformis reports Q4 loss per share $0.37
Wednesday, 15 Feb 2017 

Conformis Inc : Conformis reports fourth quarter and the year ended 2016 financial results; provides 2017 financial guidance . Q4 loss per share $0.37 . Sees FY 2017 revenue $80 million to $84 million . Q4 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S . Sees quarterly revenue $17.7 million to $18.7 million . Q4 revenue $21.7 million versus I/B/E/S view $21.6 million . For full year 2017, company expects total gross margin in a range of 36 pct to 38 pct .Impacting 2017 product revenue growth is a change in reimbursement of partial knee replacement procedures in germany.  Full Article